THE SOCIETY OF INTERVENTIONAL ONCOLOGY COMBINED LOCOREGIONAL AND IMMUNOTHERAPY OF HCC RESEARCH GRANT 

Supported by AstraZeneca

After receiving a record number of 17 highly-competitive submissions, The Society of Interventional Oncology (SIO) and the SIO Grant Review Panel, Chaired by SIO Grant Committee Chair Julius Chapiro, MD, PhD, proudly announce the recipients of the recent Combined Locoregional and Immunotherapy of HCC Call for Proposals, supported by AstraZeneca. Each recipient will be awarded $100,000 to support their research projects and will be speaking at the upcoming SIO2023 Annual Scientific Meeting.

The following investigators have been selected by the Grant Review Panel to share their accepted research proposals in-person at the SIO2023 Annual Scientific Meeting, taking place January 19-23 in Washington, D.C.

Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC

Professor S. Nahum Goldberg, MD, FSIR, FCIRSE Jerusalem, Israel | Hadassah Hebrew University

Stoking an Anti-liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant and Checkpoint Inhibitors

Isabel Gala Newton, MD, PhD San Diego, CA, United States | VA San Diego Healthcare System and UCSD Health

Engineered Extracellular Vesicles to Modulate lmmunotherapy in Liver Cancer

Kiyoyuki Minamiguchi, MD, PhD Houston, TX, United States | University of Texas MD Anderson Cancer Center

Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC

	David Tischfield, MD, PhD Philadelphia, PA, United States | University of Pennsylvania
	Kelley Weinfurtner, MD Philadelphia, PA, United States | University of Pennsylvania

.

Review the Submission Criteria

.

Questions? For administration questions contact grants@sio-central.org. For proposal inquiries, contact Grants Subcommittee Chair Dr. Julius Chapiro.